The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Beta Bionics Inc shares valued at $108,076 were sold by Feider Stephen on Oct 03 ’25. At $21.69 per share, Feider Stephen sold 4,982 shares. The insider’s holdings dropped to 44,041 shares worth approximately $0.98 million following the completion of this transaction.
Also, Feider Stephen sold 15,018 shares, netting a total of over 311,806 in proceeds. Following the sale of shares at $20.76 each, the insider now holds 44,041 shares.
Before that, Stephen Feider had added 4,982 shares to its account. In a trade valued at $108,076, the Officer bought Beta Bionics Inc shares for $21.69 each.
As published in a research note from Goldman on October 01, 2025, Beta Bionics Inc [BBNX] has been rated up from a Neutral to a Buy and the price target has been revised to $26. Analysts at Truist started covering the stock with ‘”a Buy”‘ outlook in a report released in mid June. As of June 12, 2025, Lake Street has initiated its “Buy” rating for BBNX. Earlier on May 30, 2025, Wolfe Research initiated its rating. Their recommendation was “an Outperform” for BBNX stock.
Analyzing BBNX Stock Performance
On last trading session, Beta Bionics Inc [NASDAQ: BBNX] rose 0.45% to $22.23. The stock’s lowest price that day was $21.97, but it reached a high of $23.41 in the same session. During the last five days, there has been a surge of approximately 8.49%.
Support And Resistance Levels for Beta Bionics Inc (BBNX)
According to the 24-hour chart, there is a support level at 21.66, which, if violated, would cause prices to drop to 21.10. In the upper region, resistance lies at 23.10. The next price resistance is at 23.98. RSI (Relative Strength Index) is 56.32 on the 14-day chart, showing neutral technical sentiment.
Is Beta Bionics Inc subject to short interest?
Stocks of Beta Bionics Inc saw a sharp rise in short interest on 2025-09-15 jumping by 1.21 million shares to 3.88 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 2.67 million shares. A jump of 31.27% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.52 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.52.
Which companies own the most shares of Beta Bionics Inc (BBNX)?
In terms of Beta Bionics Inc share price expectations, FactSet research, analysts set an average price target of 21.5 in the next 12 months, down nearly -2.85% from the previous closing price of $22.13. Analysts anticipate Beta Bionics Inc stock to reach 26 by 2025, with the lowest price target being 17. On May 30, 2025, Goldman assigned a price target of “a Neutral” to the stock and initiated coverage with a $16.
